Incorporating the Latest Therapeutic Strategies for HCC: Collaborating to Optimize Patient Outcomes

In this online program based on a dynamic CCO symposium from the 2019 AASLD Annual Meeting experts discuss evidence-based best practices in treating patients with advanced HCC. Watch the on-demand Webcast and download the slides now.

Share

Program Content

No activities added yet

Activities

Locoregional Therapy
Locoregional Therapy Optimization and Patient Selection in HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2019

Expires: November 08, 2020

First-line Therapy
Initial Systemic Therapy Options for Advanced, Unresectable HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2019

Expires: November 08, 2020

Second-Line Therapy
Optimal Treatment Sequence Following Disease Progression After Initial Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2019

Expires: November 08, 2020

Incorporating Immunotherapy
Incorporating Immune Checkpoint Inhibitors Into Treatment For Patients With HCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2019

Expires: November 08, 2020

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Bristol Myers Squibb

Eisai

Exelixis

Merck Oncology